WO2006122485A1 - A pharmaceutical composition for treating diabetes and process thereof - Google Patents

A pharmaceutical composition for treating diabetes and process thereof Download PDF

Info

Publication number
WO2006122485A1
WO2006122485A1 PCT/CN2006/000952 CN2006000952W WO2006122485A1 WO 2006122485 A1 WO2006122485 A1 WO 2006122485A1 CN 2006000952 W CN2006000952 W CN 2006000952W WO 2006122485 A1 WO2006122485 A1 WO 2006122485A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
parts
glibenclamide
pharmaceutical composition
added
Prior art date
Application number
PCT/CN2006/000952
Other languages
French (fr)
Chinese (zh)
Inventor
Zhang Zou
Quyi Zhong
Hong Su
Guihua Chen
Yaoxin Zheng
Original Assignee
Guangzhou Zhongyi Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Zhongyi Pharmaceutical Company Limited filed Critical Guangzhou Zhongyi Pharmaceutical Company Limited
Publication of WO2006122485A1 publication Critical patent/WO2006122485A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • A61K36/428Trichosanthes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Definitions

  • the present invention relates to a pharmaceutical composition, and more particularly to a Chinese and Western medicine combination composition for treating diabetes. It belongs to the technical field of medicines.
  • Diabetes which is called “diabetes disease” by Chinese medicine, is a common endocrine and metabolic disease characterized by high blood sugar, which is caused by absolute or relative deficiency of insulin.
  • the main clinical symptoms are: polyuria, polydipsia, polyphagia, weight loss.
  • the incidence of cardiovascular and cerebrovascular diseases, blindness and mortality in diabetic patients are 2 to 5 times higher, and the rate of lower extremity ulcers and amputation is 20 times higher.
  • diabetes has become the third largest non-communicable disease after relaying cardiovascular diseases and tumors in developed countries, and it is a worldwide public health problem that seriously threatens human health.
  • the global incidence of diabetes is about 120 million in 1994, about 135 million in 1997, about 175 million in 2000, and is expected to reach 239 million in 2010, and the number of cases will increase by 200% in developing countries, China, India, Some developing countries in Africa are the main affected areas. Both clinical and marketplaces urgently need an effective drug for the treatment of diabetes.
  • a thirst-quenching preparation is prepared, and the raw material composition thereof is pueraria 4000g, rehmannia 240g, astragalus 80g, trichosanthin 400g, corn whisker 400g, schisandra chinensis 80g, yam 40 g, glibenclamide 0.3 g composition.
  • the high dose of puerarin is used as a medicinal herb.
  • the single-flavored medicinal root is up to 4000 parts by weight, while the sum of the other medicinal herbs is only 1240 parts by weight.
  • the amount of pueraria root is much higher than that of Fangzhong.
  • the object of the present invention is achieved by the following technical solution - a pharmaceutical composition for treating diabetes, characterized in that the active ingredient of the pharmaceutical composition is as follows
  • the active ingredient of the preferred pharmaceutical composition of the present invention is prepared from the following ratios of the drug substance: - 600-900 parts by weight of Rehmannia glutinosa, 200-300 parts by weight of Astragalus, 100-150 parts by weight of Yam, 1000-1500 parts by weight of Radix Puerariae, 1000-1500 parts by weight of the smallpox, 1000-1500 parts by weight of the corn, 200-300 parts by weight of the Schisandra chinensis, and 0.2-1.0 parts by weight of glibenclamide.
  • the active ingredient of a further preferred pharmaceutical composition of the present invention is prepared from the following ratios of raw materials: 636 parts by weight of rehmannia, 212 parts by weight of astragalus, 106 parts by weight of yam, 1060 parts by weight of pueraria, 1060 parts by weight of geranium, 1060 parts by weight of corn, 1060 Parts by weight, 212 parts by weight of Schisandra chinensis, 1 part by weight of glibenclamide.
  • the pharmaceutical composition of the invention is based on the famous doctor Ye Tianshi of the Qing Dynasty, "Yuquan San” and “Xiaofang”, and functions to nourish the kidney and nourish the yin, and to replenish the vital energy.
  • Yam benefits lung spleen gas, lung and kidney yin, with the rehmannia glutinous spleen and Shengjin to tonify kidney water true yin;
  • Gegen Shengyang Shengjin help Huang Qi Sheng temper, scattered fine lungs, a total of medicine.
  • the schisandra chinensis is sour, the upper part can converge the lung yin, the lower can solidify the kidney and stimulate the body, the internal energy can stimulate the body and the nerves, the external energy can absorb the sweat, so that the water is not in a hurry, it is for the medicine; the whole party plays the kidney and nourish the yin and benefit The effect of Qishengjin.
  • this side can alleviate the symptoms of Chinese medicine for quenching thirst and achieve the purpose of lowering blood sugar.
  • the various flavors in the pharmaceutical composition of the present invention reasonably optimize the proportion and combination of the prescription, and the effect thereof is obviously superior to the "diabetes preparation" and glibenclamide, and provides for the treatment of diabetic patients.
  • a safe and effective formulation achieves the objectives of the present invention.
  • the pharmaceutical composition of the present invention can be formulated into a variety of clinically desirable dosage forms, including pills, pills, tablets, capsules, granules, soft capsules or powders, according to the technical requirements of the formulation.
  • Method 1 Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to an appropriate amount. Astragalus, Schisandra, and Yam will be pulverized into a coarse powder. Mix well with the concentrate, dry, and pulverize into fine powder. Mix well. The water is pill, dried, added with glibenclamide, coated with black iron oxide, talc and an appropriate amount of binder, light-coated, and dried to form a pellet.
  • Method 2 Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to the appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, and pulverized into fine powder. Mix well. Pills were prepared by mechanical pelleting, dried, glibenclamide was added, black iron oxide, talc and appropriate amount of binder were applied, light-coated, and dried to prepare pellets.
  • Method 3 Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to an appropriate amount. The scutellaria, schisandra, and yam are pulverized into coarse powder, mixed with the concentrate, dried, and pulverized into fine powder. Mix well. The granules were pelletized by a one-step granulator, and glibenclamide was added and compressed into pellets.
  • Method 4 Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to an appropriate amount. Astragalus, Schisandra, Yam pulverized into fine powder, and concentrate into a granulator to make granules. Glyburide is added and compressed into pellets.
  • the "diabetes preparation” was prepared by the formulation of Example 4 of the publication CN1562188A.
  • the "preparation of the present invention” was prepared by the formulation of Example 1 of the present invention.
  • the "diabetes preparation” is a sample prepared according to the formulation of Example 4 of the publication CN1562188A; the “preparation of the present invention” is a powder prepared by the prescription of the embodiment 1 of the present invention. Dilute to the desired concentration with water before the experiment.
  • Glibenclamide Product of New Technology Development Company of Tianjin Pharmaceutical Research Institute; Streptozotcin (STZ) SIGMA Chemical Company, USA; Glucose Standard Solution: Shanghai Institute of Biological Products, Ministry of Health; Glucose Oxidase: From Guangdong Provincial Clinical Testing Center purchased; Cholesterol standard solution: produced by Beijing Chemical Plant; Enzymatic triglyceride determination kit (imported packaging): Shanghai Changzheng Medical Science Co., Ltd.; High fat emulsion composition: Cholesterol: 5g, Dutch import packaging Sodium deoxycholate: 0.3g, SERVA products, New York, USA; lard: 20g (commercially available), plus Tween 80 (Japanese product packaging) and 1, 2 propylene glycol (Shanghai Reagent First Factory) , formulated into 50ml emulsion, that is.
  • mice and SD rats were provided by the Medical Laboratory Animal Farm of the Guangdong Provincial Health Department.
  • mice Thirty healthy mice weighing 23 ⁇ 25g, male and female, were randomly divided into 4 groups: normal control group was intragastrically administrated with equal volume of normal saline, positive control glibenclamide 2mg/kg was administered, "thirst The preparation group is "administered by the stomach", and the dose is equivalent to 34.94g of crude drug/kg, containing 2mg of glibenclamide, and the "prescription of the present invention” group is administered with "the preparation powder of the present invention", and is administered. The dose is equivalent to 8.64g of crude drug per kg, containing 2mg of glibenclamide.
  • Healthy rats weighing 150-180 g were selected, male and female, and after 5 days of routine feeding, fasting for 12 hours.
  • streptozotocin 50 mg/5 ml/kg, prepared in pH 4.5 in citric acid buffer
  • was quickly injected from the tail vein of the rat once was quickly injected with an equal amount of buffer.
  • Qualified diabetic rats were randomly divided into 4 groups, and a normal control group was set up.
  • the drug was administered orally once a day for four weeks.
  • the normal and model control groups were intragastrically administered with an equal volume of normal saline, and the positive control group was administered with glibenclamide 1 mg/kg, and the "diabetes preparation group" was administered with "diabetes preparation powder” at a dose equivalent to 17.47 g.
  • the amount of raw drug/kg, containing 1 mg of glibenclamide, the "preparation of the present invention” group is administered with "the preparation powder of the present invention", and the dose is equivalent to 4.32 g of the drug amount/kg, containing 1 mg of glibenclamide.
  • the blood glucose (glucose oxidase method) was taken the next day after stopping the drug to compare the differences between the groups.
  • the preparation method of streptozotocin-induced diabetic rat model is the same as experiment 1.2.2. Forty healthy diabetic rats were randomly divided into 4 groups, and a normal control group was set up. The normal and model control groups were intragastrically administered with an equal volume of normal saline, and the positive control group was administered with glibenclamide 1 mg/kg, and the "diabetes preparation group" was administered with "diabetes preparation powder" at a dose equivalent to 17.47 g.
  • the drug amount/kg contains 1 mg of glibenclamide, and the "preparation of the present invention” group is administered with "the preparation powder of the present invention", and the dose is equivalent to 4.32 g of the drug amount/kg, and contains 1 mg of glibenclamide.
  • the high-fat emulsion (5 ml/kg/time) was administered in the afternoon for 3 weeks.
  • the ether was lightly anesthetized, and the heart was taken for blood cholesterol measurement (ethanol extraction to improve iron-sulfuric acid colorimetry) and triglyceride (enzymatic method - GPO).
  • the glibenclamide group, the “prescription of the present invention” and the “diabetes preparation” have a significant effect on the blood glucose of normal mice and streptozotocin diabetic rats, and the control group. Comparing ⁇ 0.05 or P ⁇ 0.01, there was no significant difference in the hypoglycemic effect between the three; "The preparation of the present invention” has a significant inhibitory effect on the serum total cholesterol and serum triglyceride in diabetic hyperlipidemia rats, and There were significant differences between the control group, the glibenclamide group and the Xiaoke preparation.
  • the present invention rationally optimizes the proportion and combination of prescriptions, and the effect thereof is obviously superior to the "diabetes preparation” and glibenclamide, and the dosage is significantly lower than "
  • the thirst-quenching preparation is convenient for taking and carrying, and provides a safe and effective preparation for the treatment of diabetic patients, and achieves the object of the present invention.
  • the technical solutions of the present invention are further illustrated by some embodiments below.
  • the scutellaria, schisandra and yam are pulverized into a coarse powder. Mix well with the concentrate, dry, pulverize into fine powder, and mix. .
  • the water is pill, dried, added with glibenclamide, coated with black iron oxide, talc and an appropriate amount of binder, light-coated, and dried to form a pellet.
  • the scutellaria, schisandra and yam are pulverized into a coarse powder. Mix well with the concentrate, dry, pulverize into fine powder, and mix. .
  • the water is pill, dried, added with glibenclamide, coated with black iron oxide, talc and an appropriate amount of binder, light-coated, and dried to form a pellet.
  • Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid.
  • Example 4 Preparation of capsules Weigh the raw material Chinese herbal medicine and 1200 parts by weight of glibenclamide - Rehmannia glutinosa, 400 parts by weight of astragalus, 200 parts by weight of yam, 2000 parts by weight of puerarin, 2000 parts by weight of geranium powder, 2000 parts by weight of corn, and 400 parts by weight of schisandra chinensis. 2 ⁇ Glyburide 0. 2 parts by weight. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount.
  • Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid.
  • Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid.
  • Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, added.
  • the glibenclamide is mixed, and an equal amount of polyethylene glycol-400 and a small amount of glycerin are added and mixed to prepare a soft capsule.
  • rehmannia 500 parts by weight of rehmannia, 200 parts by weight of astragalus, 130 parts by weight of yam, 1100 parts by weight of puerarin, 1200 parts by weight of trichosanthin, 1300 parts by weight of corn, 250 parts by weight of schisandra, and 0.5 parts by weight of glibenclamide.
  • the scutellaria, schisandra and yam are pulverized into a coarse powder. Mix well with the concentrate, dry, pulverize into fine powder, and mix. .
  • the water is pill, dried, black iron oxide, talc and an appropriate amount of binder, and added to the glibenclamide, light-coated, dried, and made into a pellet.
  • Example 12 Preparation of pellets Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
  • the scutellaria, schisandra and yam are pulverized into a coarse powder. Mix well with the concentrate, dry, pulverize into fine powder, and mix. .
  • the water is pill, dried, black iron oxide, talc and an appropriate amount of binder, and added to the glibenclamide, light-coated, dried, and made into a pellet.
  • Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid.
  • Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid.
  • the madol is mixed, and an equal amount of polyethylene glycol-400 and a small amount of glycerin are added and mixed to prepare a soft capsule.
  • Example 16 Preparation of a powder Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

A pharmaceutical composition for treating diabetes, and process thereof. The active ingredients of the pharmaceutical composition are prepared from radix rehmanniae, radix astragali, rhizoma dioscoreae, radix puerariae, radix trichosanthis, stigma maydis, fructus schisandrae sphenantherae and glibenclamide. The pharmaceutical composition has the functions of nourishing kidney and yin, supplementing the vital energy and promoting the production of body fluid. It is used in treating diabetes due to deficiency of both vital energy and yin, namely type II diabetes.

Description

一种治疗糖尿病的药物组合物及其制备方法  Medicine composition for treating diabetes and preparation method thereof
技术领域 Technical field
本发明涉及一种药物组合物, 尤其是涉及一种用于治疗糖尿病的中西药复方组合 物。 属于药品的技术领域。  The present invention relates to a pharmaceutical composition, and more particularly to a Chinese and Western medicine combination composition for treating diabetes. It belongs to the technical field of medicines.
背景技术 Background technique
糖尿病, 即中医所称的 "消渴病", 是一种以高血糖为共同特征的常见的内分泌代 谢疾病,是由于胰岛素绝对或相对不足而引起的。主要临床症状为: 多尿、多饮、多食、 消瘦。与非糖尿病人相比,糖尿病人的心脑血管疾病、失明的发病率及其死亡率都高 2〜 5倍, 下肢溃疡及截肢率, 更是高出 20倍。 目前, 糖尿病已成为发达国家中继心血管疾 病和肿瘤之后的第三大非传染病, 是严重威胁人类健康的世界性公共卫生问题。  Diabetes, which is called "diabetes disease" by Chinese medicine, is a common endocrine and metabolic disease characterized by high blood sugar, which is caused by absolute or relative deficiency of insulin. The main clinical symptoms are: polyuria, polydipsia, polyphagia, weight loss. Compared with non-diabetics, the incidence of cardiovascular and cerebrovascular diseases, blindness and mortality in diabetic patients are 2 to 5 times higher, and the rate of lower extremity ulcers and amputation is 20 times higher. At present, diabetes has become the third largest non-communicable disease after relaying cardiovascular diseases and tumors in developed countries, and it is a worldwide public health problem that seriously threatens human health.
据调査,全球糖尿病发病人数 1994年约 1.20亿, 1997年约 1.35亿, 2000年约 1.75 亿, 预计 2010年将达 2.39亿, 并且发病人数在发展中国家将上升 200%, 中国、 印度、 非洲的某些发展中国家是主要发病地区。临床与市场都迫切需要一种高效的治疗糖尿病 的药物。  According to the survey, the global incidence of diabetes is about 120 million in 1994, about 135 million in 1997, about 175 million in 2000, and is expected to reach 239 million in 2010, and the number of cases will increase by 200% in developing countries, China, India, Some developing countries in Africa are the main affected areas. Both clinical and marketplaces urgently need an effective drug for the treatment of diabetes.
目前国内外多采用化学合成药物对糖尿病进行治疗, 其近期效果满意, 但远期效果 不佳, 易产生副作用和并发症。  At present, the use of chemical synthetic drugs for the treatment of diabetes at home and abroad, the recent results are satisfactory, but the long-term effect is not good, easy to produce side effects and complications.
2005年 1月 12日公开的发明专利申请公开说明书 CN1562188A中, 公幵了一种消 渴制剂, 其原料组成为葛根 4000g、 地黄 240g、 黄芪 80g、 天花粉 400g、 玉米须 400g、 南五味子 80g、 山药 40g、 格列本脲 0.3g组成。 该组方大剂量重用葛根为君药, 在原料 药组成比例上, 单味药葛根高达 4000重量份, 而其余各味药总和仅占 1240重量份, 该 方的葛根用量远远高于方中其它诸药, 并且大大高于《中国药典》的临床常用量, 也影 响了方中其它各药作用的有效发挥, 处方组成明显不合理, 且根据该发明公开的制备方 法, 由于葛根的浸膏收膏率较高, 制成的制剂量较大, 不便于服用及携带。  In the invention patent application publication CN1562188A published on January 12, 2005, a thirst-quenching preparation is prepared, and the raw material composition thereof is pueraria 4000g, rehmannia 240g, astragalus 80g, trichosanthin 400g, corn whisker 400g, schisandra chinensis 80g, yam 40 g, glibenclamide 0.3 g composition. In this group, the high dose of puerarin is used as a medicinal herb. In the proportion of raw materials, the single-flavored medicinal root is up to 4000 parts by weight, while the sum of the other medicinal herbs is only 1240 parts by weight. The amount of pueraria root is much higher than that of Fangzhong. Other medicines, and much higher than the clinical doses of the Chinese Pharmacopoeia, also affect the effective function of the other drugs in the prescription, the prescription composition is obviously unreasonable, and according to the preparation method disclosed by the invention, due to the extract of Pueraria The rate of the paste is high, and the amount of the preparation is large, which is not convenient to take and carry.
发明内容 Summary of the invention
本发明的目的在于提供一种新的药物组合物, 合物可以协调方中—各种药物的特 点, 发挥各药物的最佳治疗效果。  SUMMARY OF THE INVENTION It is an object of the present invention to provide a novel pharmaceutical composition which can coordinate the characteristics of various drugs in various ways to exert the optimal therapeutic effect of each drug.
本发明的目的是通过如下技术方案实现的- 一种治疗糖尿病的药物组合物,其特征在于该药物组合物的活性成分是由如下比例 The object of the present invention is achieved by the following technical solution - a pharmaceutical composition for treating diabetes, characterized in that the active ingredient of the pharmaceutical composition is as follows
确 认 本 的原料药制成的- 地黄 600-1200重量份,黄芪 200-400重量份,山药 100-200重量份,葛根 1000-2000 重量份, 天花粉 1000- 2000重量份, 玉米须 1000- 2000重量份, 南五味子 200-400重量 份, 格列本脲 0. 2-1. 5重量份。 Confirmation Made of raw materials - 600-1200 parts by weight of Radix Rehmanniae, 200-400 parts by weight of Astragalus, 100-200 parts by weight of yam, 1000-2000 parts by weight of Pueraria, 1000-2000 parts by weight of Tianhuan, 1000-2000 parts by weight of corn, 5重量份。 The schisandra chinensis 200-400 parts by weight, glibenclamide 0. 2-1. 5 parts by weight.
本发明优选的药物组合物的活性成分是由如下比例的原料药制成的: - 地黄 600-900重量份,黄芪 200-300重量份, 山药 100-150重量份,葛根 1000-1500 重量份, 天花粉 1000-1500重量份, 玉米须 1000- 1500重量份, 南五味子 200-300重量 份, 格列本脲 0. 2- 1. 0重量份。  The active ingredient of the preferred pharmaceutical composition of the present invention is prepared from the following ratios of the drug substance: - 600-900 parts by weight of Rehmannia glutinosa, 200-300 parts by weight of Astragalus, 100-150 parts by weight of Yam, 1000-1500 parts by weight of Radix Puerariae, 1000-1500 parts by weight of the smallpox, 1000-1500 parts by weight of the corn, 200-300 parts by weight of the Schisandra chinensis, and 0.2-1.0 parts by weight of glibenclamide.
本发明进一步优选的药物组合物的活性成分是由如下比例的原料药制成的: 地黄 636重量份, 黄芪 212重量份, 山药 106重量份, 葛根 1060重量份, 天花粉 1060重量份, 玉米须 1060重量份, 南五味子 212重量份, 格列本脲 1重量份。  The active ingredient of a further preferred pharmaceutical composition of the present invention is prepared from the following ratios of raw materials: 636 parts by weight of rehmannia, 212 parts by weight of astragalus, 106 parts by weight of yam, 1060 parts by weight of pueraria, 1060 parts by weight of geranium, 1060 parts by weight of corn, 1060 Parts by weight, 212 parts by weight of Schisandra chinensis, 1 part by weight of glibenclamide.
本发明的药物组合物是以清代名医叶天仕 "玉泉散"与 "消渴方"为基础方化裁而 来, 功能滋肾养阴,益气生津。 方中地黄滋肾养阴; 黄芪益气, 紧固腠理, 生津止渴, 共为君药。 山药益肺脾之气、 补肺肾之阴, 配合地黄养阴生津以补肾水真阴; 葛根升阳 生津, 助黄芪升脾气, 散精达肺, 共为臣药。 天花粉清胃热、 养胃阴, 润肺燥, 去上中 焦之烦渴; 玉米须利水消肿, 使肾开阖固摄有序, 共为佐药。 南五味子酸淫, 上能敛肺 阴, 下能固肾生津, 内能生津安神, 外能敛汗, 使水液不急于下趋, 是为使药; 全方共 奏滋肾养阴、 益气生津之功效。 结合西药格列本脲使本方既缓解了消渴的中医症状, 又 达到了降低血糖目的。  The pharmaceutical composition of the invention is based on the famous doctor Ye Tianshi of the Qing Dynasty, "Yuquan San" and "Xiaofang", and functions to nourish the kidney and nourish the yin, and to replenish the vital energy. Fangzhongdi Huang Zishen Yangyin; Huangqi Yiqi, fastening phlegm, Shengjinzhike, a total of medicine. Yam benefits lung spleen gas, lung and kidney yin, with the rehmannia glutinous spleen and Shengjin to tonify kidney water true yin; Gegen Shengyang Shengjin, help Huang Qi Sheng temper, scattered fine lungs, a total of medicine. Tianhua powder clear stomach heat, nourishing stomach yin, moist lung dryness, go to the middle of the coke quenching; corn must be water swelling, so that the kidney is open and fixed, ordering, a total of adjuvant. The schisandra chinensis is sour, the upper part can converge the lung yin, the lower can solidify the kidney and stimulate the body, the internal energy can stimulate the body and the nerves, the external energy can absorb the sweat, so that the water is not in a hurry, it is for the medicine; the whole party plays the kidney and nourish the yin and benefit The effect of Qishengjin. Combined with the western medicine glibenclamide, this side can alleviate the symptoms of Chinese medicine for quenching thirst and achieve the purpose of lowering blood sugar.
本发明的药物组合物中的各味药根据中医药理论及本品的实际应用,合理优化处方 比例及组合, 其效果明显优于 "消渴制剂"及格列本脲, 为糖尿病患者的治疗提供了一 个安全、 有效的制剂, 达到了本发明的目的。  According to the theory of traditional Chinese medicine and the practical application of the product, the various flavors in the pharmaceutical composition of the present invention reasonably optimize the proportion and combination of the prescription, and the effect thereof is obviously superior to the "diabetes preparation" and glibenclamide, and provides for the treatment of diabetic patients. A safe and effective formulation achieves the objectives of the present invention.
将本发明的药物组合物, 按照制剂学技术要求, 可以制成多种临床所需剂型, 包括 滴丸剂、 丸剂、 片剂、 胶囊剂、 颗粒剂、 软胶囊剂或散剂。  The pharmaceutical composition of the present invention can be formulated into a variety of clinically desirable dosage forms, including pills, pills, tablets, capsules, granules, soft capsules or powders, according to the technical requirements of the formulation.
以下分别说明各种常用剂型的制剂过程:  The following describes the preparation process of various commonly used dosage forms:
1、 滴丸剂的制备:  1. Preparation of pills:
取葛根、 地黄、 玉米须、 天花粉、 黄芪、 南五味子、 山药加水煎煮一次, 滤过, 滤 液浓缩至适量, 放冷, 加乙醇使溶液含醇量为 60%, 静置 24小时, 滤过, 滤液浓缩至 无醇味,加入 2倍水量于浓缩膏中,搅拌溶解完全后,通过预先处理过的大孔吸附树脂, 并以水洗脱至流出液无色后, 以 70%乙醇洗脱, 收集洗脱液至无色后, 浓缩得浸膏。 取 聚乙二醇 6000 (PEG-6000)和硬脂酸适量至容器中,加热至 100~110°C,待全部熔融后, 加入格列本脲和上述浸膏, 分散均匀后, 以液体石蜡为冷却剂滴制成丸, 取出滴丸, 甩 干石蜡, 即得滴丸剂。 Take radix puerariae, rehmannia root, corn stalk, trichosanthin, astragalus, schisandra, yam and boiled water once, filter, filter the filtrate to the appropriate amount, let cool, add ethanol to make the solution alcohol content 60%, let stand for 24 hours, filter The filtrate is concentrated to an alcohol-free taste, and 2 times the amount of water is added to the concentrated paste, and after stirring and dissolving completely, the pretreated macroporous adsorption resin is passed. After eluting with water until the effluent was colorless, it was eluted with 70% ethanol, and the eluate was collected until it was colorless, and concentrated to obtain an extract. Take polyethylene glycol 6000 (PEG-6000) and stearic acid into the container, heat to 100 ~ 110 ° C, after all melting, add glibenclamide and the above extract, evenly dispersed, with liquid paraffin Pills are prepared by dropping the coolant, and the dropping pills are taken out, and the paraffin is dried, that is, the pills are obtained.
2、 丸剂的制备: 2. Preparation of pills:
方法 1 : 取地黄、 葛根、 天花粉、玉米须加水煎煮五小时, 滤过, 滤液浓缩至适量, 黄芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 混匀。 水泛为 丸, 干燥, 加入格列本脲, 用黑氧化铁、 滑石粉和适量粘合剂, 打光包衣, 干燥, 制成 丸剂。  Method 1: Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to an appropriate amount. Astragalus, Schisandra, and Yam will be pulverized into a coarse powder. Mix well with the concentrate, dry, and pulverize into fine powder. Mix well. The water is pill, dried, added with glibenclamide, coated with black iron oxide, talc and an appropriate amount of binder, light-coated, and dried to form a pellet.
方法 2: 取地黄、 葛根、天花粉、玉米须加水煎煮五小时, 滤过, 滤液浓缩至适量, 黄芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 混匀。 以机械 制丸机制成丸, 干燥, 加入格列本脲, 用黑氧化铁、 滑石粉和适量粘合剂, 打光包衣, 干燥, 制成丸剂。  Method 2: Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to the appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, and pulverized into fine powder. Mix well. Pills were prepared by mechanical pelleting, dried, glibenclamide was added, black iron oxide, talc and appropriate amount of binder were applied, light-coated, and dried to prepare pellets.
方法 3: 取地黄、 葛根、 天花粉、玉米须加水煎煮五小时, 滤过, 滤液浓缩至适量, 黄芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 混匀。 以一步 制粒机制成颗粒, 加入格列本脲, 压制成丸剂。  Method 3: Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to an appropriate amount. The scutellaria, schisandra, and yam are pulverized into coarse powder, mixed with the concentrate, dried, and pulverized into fine powder. Mix well. The granules were pelletized by a one-step granulator, and glibenclamide was added and compressed into pellets.
方法 4: 取地黄、 葛根、 天花粉、玉米须加水煎煮五小时, 滤过, 滤液浓缩至适量, 黄芪、南五味子、山药粉碎成细粉, 与浓缩液到一步制粒机中制成颗粒,加入格列本脲, 压制成丸剂。  Method 4: Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to an appropriate amount. Astragalus, Schisandra, Yam pulverized into fine powder, and concentrate into a granulator to make granules. Glyburide is added and compressed into pellets.
3、 胶囊剂的制备: 3. Preparation of capsules:
取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混匀、 制粒, 充填, 制成胶囊剂。  Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. Lebenone and appropriate amount of dextrin, mixed, granulated, filled, and made into capsules.
4、 片剂的制备- 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混匀, 制成颗粒, 干燥, 拌入 0. 5%硬脂酸镁, 压成片剂。  4. Preparation of tablets - Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, Corn must be boiled for one hour for five hours, filtered, and the filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, and mixed with the concentrate, dried. The granules are added to the granules, and the granules are added to the granules. The granules are added to the granules, and the mixture is granulated, dried, and mixed with 0.5% magnesium stearate and compressed into tablets.
5、 颗粒剂的制备:  5. Preparation of granules:
取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混匀、 制成颗粒剂。 Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to a suitable amount. 芪, nanzizi, yam crushed into coarse powder, mix well with the concentrate, dry, pulverize into fine powder, add glibenclamide and appropriate amount of dextrin, mix and prepare granules.
6、 软胶囊剂的制备:  6, the preparation of soft capsules:
取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲混 匀, 再加入等量的聚乙二醇 -400和少量的丙三醇, 混匀, 压制成软胶囊。  Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. The lebenol is mixed, and an equal amount of polyethylene glycol-400 and a small amount of glycerin are added, mixed, and compressed into soft capsules.
7、 散剂的制备- 取地黄、葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲, 混匀、 制成散剂。  7. Preparation of powder - Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, Corn must be boiled for one hour for five hours, filtered, and the filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, smashed. To form a fine powder, add glibenclamide, mix and prepare a powder.
以下通过工艺研究, 说明本发明药物组合物的工艺稳定, 质量可控:  The following is a process study to demonstrate that the pharmaceutical composition of the present invention is stable in process and controllable in quality:
1. 材料与方法  1. Materials and methods
1. 1材料  1. 1 material
"消渴制剂"是以公开文件 CN1562188A中实施例 4处方制备而得制剂。  The "diabetes preparation" was prepared by the formulation of Example 4 of the publication CN1562188A.
"本发明制剂"是按本发明的实施例 1处方制备而得制剂。  The "preparation of the present invention" was prepared by the formulation of Example 1 of the present invention.
1. 2方法  1. 2 methods
稠膏量 X干固物含量  Thick paste amount X dry solid content
1. 2. 1浸膏收得率 = X 100%  1. 2. 1 extract yield = X 100%
提取药材量  Extracting the amount of medicine
1. 2. 2其他项目: 按 2000年版《中国药典》一部附录  1. 2. 2 Other items: According to the 2000 edition of the Chinese Pharmacopoeia
2. 数据:  2. Data:
Figure imgf000005_0001
Figure imgf000005_0001
结论: 由以上实验结果可见, 与 "消渴制剂"相比, "本发明制剂"组方更合理、 工艺 更稳定、 服用量更小, 制成的产品质量稳定、 可控。 本发明的组合物与现有技术相比具 有良好的制剂稳定性, 制成品具有良好的溶散(崩解) 性能和制剂均匀性。 以下通过动物药效学实验, 说明本发明药物组合物的治疗效果。 Conclusion: It can be seen from the above experimental results that the "prescription of the present invention" is more reasonable and the process is better than the "diabetes preparation". It is more stable and consumes less, and the quality of the finished product is stable and controllable. The composition of the present invention has good formulation stability as compared with the prior art, and the finished product has good disintegration (disintegration) properties and formulation uniformity. The therapeutic effects of the pharmaceutical composition of the present invention are illustrated below by animal pharmacodynamic experiments.
1材料与方法  1 Materials and methods
1. 1材料  1. 1 material
1. 1. 1药物与试剂  1. 1. 1 drugs and reagents
"消渴制剂"是按公开文件 CN1562188A实施例 4处方制备而得的样品; "本发明 制剂"则是按本发明实施例 1处方制备而得的药粉。 实验前用水稀释至所需浓度。  The "diabetes preparation" is a sample prepared according to the formulation of Example 4 of the publication CN1562188A; the "preparation of the present invention" is a powder prepared by the prescription of the embodiment 1 of the present invention. Dilute to the desired concentration with water before the experiment.
格列本脲:天津药物研究所新技术开发公司产品;链脲佐菌素(Streptozotcin, STZ) 美国 SIGMA化学公司产品; 葡萄糖标准液: 卫生部上海生物制品研究所产品; 葡萄糖 氧化酶: 由广东省临床检验中心购入; 胆固醇标准液: 北京化工厂出品; 酶法甘油三脂 测定药盒(进口分装): 上海长征医学科学有限公司; 高脂乳剂组成: 胆固醇: 5g, 荷 兰进口分装; 去氧胆酸钠: 0.3g, 美国纽约 SERVA公司产品; 猪油: 20g (市售), 加 吐温 80 (日本进品分装)及 1、 2丙二醇(上海试剂一厂产品)各半, 配制成 50ml乳 剂, 即得。  Glibenclamide: Product of New Technology Development Company of Tianjin Pharmaceutical Research Institute; Streptozotcin (STZ) SIGMA Chemical Company, USA; Glucose Standard Solution: Shanghai Institute of Biological Products, Ministry of Health; Glucose Oxidase: From Guangdong Provincial Clinical Testing Center purchased; Cholesterol standard solution: produced by Beijing Chemical Plant; Enzymatic triglyceride determination kit (imported packaging): Shanghai Changzheng Medical Science Co., Ltd.; High fat emulsion composition: Cholesterol: 5g, Dutch import packaging Sodium deoxycholate: 0.3g, SERVA products, New York, USA; lard: 20g (commercially available), plus Tween 80 (Japanese product packaging) and 1, 2 propylene glycol (Shanghai Reagent First Factory) , formulated into 50ml emulsion, that is.
1. 1. 2主要仪器 BBO型全自动生化分析仪: 美国康宁公司产品。  1. 1. 2 main instruments BBO automatic biochemical analyzer: Corning, the United States products.
1.1.3动物 MH系小鼠, SD系大鼠均由广东省卫生厅医用实验动物场提供。  1.1.3 Animals MH mice and SD rats were provided by the Medical Laboratory Animal Farm of the Guangdong Provincial Health Department.
1. 2方法  1. 2 methods
1.2.1对正常小鼠血糖的影响  1.2.1 Effects on blood glucose in normal mice
选取体重为 23〜25g的健康小鼠 40只, 雌雄各半, 随机分为 4组: 正常对照组用 等体积生理盐水灌胃, 阳性对照组格列本脲 2mg/kg灌胃, "消渴制剂组 "灌胃 "消渴 制剂药粉", 给药剂量相当于 34. 94g生药量 /kg,内含 2mg格列本脲, "本发明制剂" 组灌胃 "本发明制剂药粉", 给药剂量相当于 8. 64g生药量 /kg, 内含 2mg格列本脲。 常规饲养 3天后, 禁食 12小时, 眼眶取血, 葡萄糖氧化酶法测定血糖, 作为基础血糖 值, 然后经口灌胃给药, 并分别于给药后第 3、 第 7小时各测定血糖 1次。 将基础血糖 值减去给药后血糖值作为给药后血糖下降值。  Thirty healthy mice weighing 23~25g, male and female, were randomly divided into 4 groups: normal control group was intragastrically administrated with equal volume of normal saline, positive control glibenclamide 2mg/kg was administered, "thirst The preparation group is "administered by the stomach", and the dose is equivalent to 34.94g of crude drug/kg, containing 2mg of glibenclamide, and the "prescription of the present invention" group is administered with "the preparation powder of the present invention", and is administered. The dose is equivalent to 8.64g of crude drug per kg, containing 2mg of glibenclamide. After 3 days of routine feeding, fasting for 12 hours, blood was taken from the eyelids, blood glucose was measured by glucose oxidase method, and the blood glucose level was used as a basic blood glucose level, and then administered by oral gavage, and blood glucose was measured at 3 and 7 hours after administration, respectively. Times. The basal blood glucose level is subtracted from the blood glucose level after administration as the blood glucose drop value after administration.
1.2.2对链脲佐菌素所致糖尿病大鼠血糖的影响  1.2.2 Effect of streptozotocin on blood glucose in diabetic rats
选取体重为 150〜180g的健康大鼠, 雌雄各半, 常规饲养 5天后, 禁食 12小时, 按文献的方法, 由大鼠尾静脉快速注射链脲佐菌素 (50mg/5ml/kg, 用 PH4.5的枸椽酸 缓冲液配制)一次, 正常组注射等量的缓冲液。 两周后取血测血糖, 选取血糖值高于 16.8mmol/L及尿糖连续 +++以上的大鼠, 作为合格的糖尿病大鼠。 Healthy rats weighing 150-180 g were selected, male and female, and after 5 days of routine feeding, fasting for 12 hours. According to the literature method, streptozotocin (50 mg/5 ml/kg, prepared in pH 4.5 in citric acid buffer) was quickly injected from the tail vein of the rat once, and the normal group was injected with an equal amount of buffer. Two weeks later, blood was taken for blood glucose measurement, and rats with blood glucose levels higher than 16.8 mmol/L and urine sugar continuously +++ or more were selected as qualified diabetic rats.
合格糖尿病大鼠随机分为 4组, 另设一组正常对照组。每日经口灌服药物 1次,连 续四周。 其中正常及模型对照组用等体积生理盐水灌胃, 阳性对照组格列本脲 lmg/kg 灌胃, "消渴制剂组"灌胃 "消渴制剂药粉", 给药剂量相当于 17. 47g生药量 /kg,内 含 lmg格列本脲, "本发明制剂"组灌胃 "本发明制剂药粉", 给药剂量相当于 4. 32g 生药量 /kg, 内含 lmg格列本脲。 停药后次日取血测血糖(葡萄糖氧化酶法) 比较各组 的差异。  Qualified diabetic rats were randomly divided into 4 groups, and a normal control group was set up. The drug was administered orally once a day for four weeks. The normal and model control groups were intragastrically administered with an equal volume of normal saline, and the positive control group was administered with glibenclamide 1 mg/kg, and the "diabetes preparation group" was administered with "diabetes preparation powder" at a dose equivalent to 17.47 g. The amount of raw drug/kg, containing 1 mg of glibenclamide, the "preparation of the present invention" group is administered with "the preparation powder of the present invention", and the dose is equivalent to 4.32 g of the drug amount/kg, containing 1 mg of glibenclamide. The blood glucose (glucose oxidase method) was taken the next day after stopping the drug to compare the differences between the groups.
1.2.3对糖尿病合并高血脂大鼠胆固醇、 甘油三脂、 肝、 肾功能以及血液流变学的 影响  1.2.3 Effects on cholesterol, triglyceride, liver and kidney function and hemorheology in diabetic rats with hyperlipidemia
链脲佐菌素致糖尿病大鼠模型的制备方法, 同实验 1.2.2。 选取合格的糖尿病大鼠 40只,随机分成 4组, 另设一组正常对照组。其中正常及模型对照组用等体积生理盐水 灌胃, 阳性对照组格列本脲 lmg/kg灌胃, "消渴制剂组"灌胃 "消渴制剂药粉", 给 药剂量相当于 17. 47g生药量 /kg,内含 lmg格列本脲, "本发明制剂"组灌胃 "本发明 制剂药粉", 给药剂量相当于 4. 32g生药量 /kg, 内含 lmg格列本脲。 在每天上午灌胃 给药的同时, 于下午灌服高脂乳剂(5ml/kg/次), 连续 3周。 停药后禁食 12小时, 乙醚 浅麻醉, 心脏取血测胆固醇(乙醇抽提高铁一硫酸显色法) 及甘油三脂(酶学法—— GPO)。 The preparation method of streptozotocin-induced diabetic rat model is the same as experiment 1.2.2. Forty healthy diabetic rats were randomly divided into 4 groups, and a normal control group was set up. The normal and model control groups were intragastrically administered with an equal volume of normal saline, and the positive control group was administered with glibenclamide 1 mg/kg, and the "diabetes preparation group" was administered with "diabetes preparation powder" at a dose equivalent to 17.47 g. The drug amount/kg contains 1 mg of glibenclamide, and the "preparation of the present invention" group is administered with "the preparation powder of the present invention", and the dose is equivalent to 4.32 g of the drug amount/kg, and contains 1 mg of glibenclamide. At the same time as the morning administration, the high-fat emulsion (5 ml/kg/time) was administered in the afternoon for 3 weeks. After stopping the drug for 12 hours, the ether was lightly anesthetized, and the heart was taken for blood cholesterol measurement (ethanol extraction to improve iron-sulfuric acid colorimetry) and triglyceride (enzymatic method - GPO).
1. 3统计学处理数据以 ±s表示, 组间差异采用 t检验方法。  1. 3 Statistical analysis data are expressed as ± s, and differences between groups are determined by t test.
2结果  2 results
2. 1对正常小鼠血糖的影响 (结果见表 1 )  2. 1 effect on blood glucose in normal mice (see Table 1 for results)
表 1 对正常小鼠血糖的影响 ( ±s, n=10)  Table 1 Effect on blood glucose in normal mice (±s, n=10)
剂 量 基¾»糖值 药后血 降值(mmol L) 组 别  Dosage base 3⁄4» sugar value post-drug blood drop (mmol L) group
(g kg) (mmol/L) 药后 3h 药后 7h  (g kg) (mmol/L) 3h after drug 7h after drug
对 照 4.70+0.90 1.37± 0.93 0.99+ 1.17  4.70+0.90 1.37± 0.93 0.99+ 1.17
格列本脲 2X 10-3 5.26+ 1.59 2.07 ± 0.46* 3.23+ 1.57** 消渴制剂 34.94 4.83 ± 1.23 2.12± 0. 63* 3.17 ± 1.67** 本发明制剂 8.64 5.14± 1.52 2.25 ±0. 42* 3.43 ± 1.55** 注: 与对照组比较: *P<0.05; **P<0.01 (下同) Glibenclamide 2X 10-3 5.26+ 1.59 2.07 ± 0.46* 3.23+ 1.57** Diabetes preparation 34.94 4.83 ± 1.23 2.12 ± 0. 63* 3.17 ± 1.67** Preparation of the invention 8.64 5.14 ± 1.52 2.25 ±0. 42 * 3.43 ± 1.55** Note: Compared with the control group: *P<0.05;**P<0.01 (the same below)
2.2对链脲佐菌素糖尿病大鼠血糖的影响 (结果见表 2) 2.2 Effect on blood glucose of streptozotocin-induced diabetic rats (see Table 2 for results)
表 2 对链脲佐菌素糖尿病大鼠血糖的影响 ( ±s,  Table 2 Effect on blood glucose of streptozotocin-induced diabetic rats (±s,
剂量 血糖值 (mmol/L)  Dose blood glucose value (mmol/L)
组 别  Group
X (gkg) 用药前 用药后下降值  X (gkg) before drug use
ο  ο
正 常 5.56±0.95 0.25±0.11  Normal 5.56±0.95 0.25±0.11
对 照 24.23 ±3.94 -1.52±4.69  Photograph 24.23 ±3.94 -1.52±4.69
格列本脲 1X10-3 25.64±3.47 2.90±3.02*  Glibenclamide 1X10-3 25.64±3.47 2.90±3.02*
消渴制剂 17.47 25.19±2.98 3.05 ±1.90*  Diabetes preparation 17.47 25.19±2.98 3.05 ±1.90*
本发明制剂 4.32 24.69±3.73 3.66 ±2.57**  Formulation of the invention 4.32 24.69±3.73 3.66 ±2.57**
2.3对糖尿病合并高血脂大鼠胆固醇、 甘油三酯的影响 (结果见表 3) 2.3 Effects on cholesterol and triglyceride in diabetic rats with hyperlipidemia (Results are shown in Table 3)
表 3 对糖尿病合并高血脂大鼠胆固醇、 甘油三酯的影响 ( ±s, η=ΪΟ)  Table 3 Effect on cholesterol and triglyceride in diabetic rats with hyperlipidemia (±s, η=ΪΟ)
剂量 血清总胆固醇 血清甘油三酯  Dose serum total cholesterol serum triglyceride
组 别  Group
(gkg) (mmol/L) (mmolL)  (gkg) (mmol/L) (mmolL)
正 常 0.60±0.28 1.48 ±0.49  Normal 0.60±0.28 1.48 ±0.49
对 照 1·59±0.51 2.96 ±1.45  Photograph 1.59±0.51 2.96 ±1.45
格列本脲 1.44±0.43 2.52±1.12  Glibenclamide 1.44±0.43 2.52±1.12
消渴制剂 17.47 1.25 ±0.33 1.95±0.71  Diabetes preparation 17.47 1.25 ±0.33 1.95±0.71
本发明制剂 4.32 0.96+0.21**ΛΛ 1.58±0.71*Δ  Formulation of the invention 4.32 0.96+0.21**ΛΛ 1.58±0.71*Δ
与格列本脲与消渴制剂组相比较, AP<0.05, AAP〈0.01。  Compared with the glibenclamide and the diabetes-preventing group, AP<0.05 and AAP<0.01.
结论: in conclusion:
1. 由以上实验结果可见,格列本脲组、 "本发明制剂"及 "消渴制剂"对正常小鼠、 链脲佐菌素糖尿病大鼠血糖均有较显著的降低作用, 与对照组比较 <0.05或 P<0.01, 三者之间的降糖效果无明显差异; "本发明制剂"对糖尿病合并高血脂大鼠血清总胆固 醇及血清甘油三酯有明显的抑制升高作用, 与 "对照组"、 "格列本脲组"、 "消渴制剂" 比较有显著性差异, PO.05或尸<0.01; "格列本脲组"、 "消渴制剂"对糖尿病合并高血 脂大鼠血清总胆固醇及血清甘油三酯均无抑制升高作用, "本发明制剂"的效果优于"消 渴制剂"和格列本脲组。 1. It can be seen from the above experimental results that the glibenclamide group, the "prescription of the present invention" and the "diabetes preparation" have a significant effect on the blood glucose of normal mice and streptozotocin diabetic rats, and the control group. Comparing <0.05 or P<0.01, there was no significant difference in the hypoglycemic effect between the three; "The preparation of the present invention" has a significant inhibitory effect on the serum total cholesterol and serum triglyceride in diabetic hyperlipidemia rats, and There were significant differences between the control group, the glibenclamide group and the Xiaoke preparation. PO.05 or corpse <0.01;"glibenclamidegroup" and "diabetes preparation" had high blood fat and diabetes The serum total cholesterol and serum triglyceride did not inhibit the increase, and the effect of the "prescription of the present invention" was better than that of "the elimination". Thirsty preparation" and glibenclamide group.
2. 本发明对处方中各味药根据中医药理论及本品的实际应用, 合理优化处方比例 及组合, 其效果明显优于 "消渴制剂"及格列本脲, 且服用剂量明显低于 "消渴制剂", 便于服用及携带, 为糖尿病患者的治疗提供了一个安全、有效的制剂, 达到了本发明的 目的。 以下通过一些实施例来进一步说明本发明的技术方案。  2. According to the traditional Chinese medicine theory and the practical application of the product, the present invention rationally optimizes the proportion and combination of prescriptions, and the effect thereof is obviously superior to the "diabetes preparation" and glibenclamide, and the dosage is significantly lower than " The thirst-quenching preparation is convenient for taking and carrying, and provides a safe and effective preparation for the treatment of diabetic patients, and achieves the object of the present invention. The technical solutions of the present invention are further illustrated by some embodiments below.
实施例 1 : 丸剂的制备  Example 1 : Preparation of pellets
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 636重量份, 黄芪 212重量份, 山药 106重量份, 葛根 1060重量份, 天花粉 1060重量份, 玉米须 1060重量份, 南五味子 212重量份, 格列本脲 1重量份 。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 混匀。水泛为丸, 干燥,加入格列本脲,用黑氧化铁、滑石粉和适量粘合剂, 打光包衣, 干燥, 制成丸剂。  Rehmannia 636 parts by weight, astragalus 212 parts by weight, yam 106 parts by weight, puerarin 1060 parts by weight, 10,60 parts by weight of trichosanthin, 1060 parts by weight of corn, 212 parts by weight of schisandra, and 1 part by weight of glibenclamide. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, Corn, and boil for one hour. Add the filtrate to the appropriate amount. The scutellaria, schisandra and yam are pulverized into a coarse powder. Mix well with the concentrate, dry, pulverize into fine powder, and mix. . The water is pill, dried, added with glibenclamide, coated with black iron oxide, talc and an appropriate amount of binder, light-coated, and dried to form a pellet.
实施例 2: 丸剂的制备  Example 2: Preparation of pellets
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 600重量份, 黄芪 200重量份, 山药 100重量份, 葛根 1000重量份, 天花粉 1000重量份, 玉米须 1000重量份, 南五味子 200重量份, 格列本脲 1. 5重量份。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 混匀。水泛为丸, 干燥,加入格列本脲,用黑氧化铁、滑石粉和适量粘合剂, 打光包衣, 干燥, 制成丸剂。  Rehmannia 600 parts by weight, Astragalus 200 parts by weight, Yam 100 parts by weight, Pueraria 1000 parts by weight, Trichosanthin 1000 parts by weight, Corn must be 1000 parts by weight, South Schisandra 200 parts by weight, Glibenclamide 1.5 parts by weight. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, Corn, and boil for one hour. Add the filtrate to the appropriate amount. The scutellaria, schisandra and yam are pulverized into a coarse powder. Mix well with the concentrate, dry, pulverize into fine powder, and mix. . The water is pill, dried, added with glibenclamide, coated with black iron oxide, talc and an appropriate amount of binder, light-coated, and dried to form a pellet.
实施例 3: 胶囊剂的制备  Example 3: Preparation of capsules
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 636重量份, 黄芪 212重量份, 山药 106重量份, 葛根 1060重量份, 天花粉 1060重量份, 玉米须 1060重量份, 南五味子 212重量份, 格列本脲 1重量份 。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混匀、 制粒, 充填成胶囊。  Rehmannia 636 parts by weight, astragalus 212 parts by weight, yam 106 parts by weight, puerarin 1060 parts by weight, 10,60 parts by weight of trichosanthin, 1060 parts by weight of corn, 212 parts by weight of schisandra, and 1 part by weight of glibenclamide. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. Lebenone and an appropriate amount of dextrin, mixed, granulated, and filled into capsules.
实施例 4: 胶囊剂的制备 按照下列用量称取原料中药材及格列本脲- 地黄 1200重量份, 黄芪 400重量份, 山药 200重量份, 葛根 2000重量份, 天花粉 2000重量份, 玉米须 2000重量份, 南五味子 400重量份, 格列本脲 0. 2重量份 。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混匀、 制粒, 充填成胶囊。 ' Example 4: Preparation of capsules Weigh the raw material Chinese herbal medicine and 1200 parts by weight of glibenclamide - Rehmannia glutinosa, 400 parts by weight of astragalus, 200 parts by weight of yam, 2000 parts by weight of puerarin, 2000 parts by weight of geranium powder, 2000 parts by weight of corn, and 400 parts by weight of schisandra chinensis. 2重量份。 Glyburide 0. 2 parts by weight. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. Lebenone and an appropriate amount of dextrin, mixed, granulated, and filled into capsules. '
实施例 5: 片剂的制备  Example 5: Preparation of tablets
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 636重量份, 黄芪 212重量份, 山药 106重量份, 葛根 1060重量份, 天花粉 1060重量份, 玉米须 1060重量份, 南五味子 212重量份, 格列本脲 1重量份 。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混匀, 制成颗粒, 干燥, 拌入 0. 5 %硬脂酸镁, 压制成片剂。  Rehmannia 636 parts by weight, astragalus 212 parts by weight, yam 106 parts by weight, puerarin 1060 parts by weight, 10,60 parts by weight of trichosanthin, 1060 parts by weight of corn, 212 parts by weight of schisandra, and 1 part by weight of glibenclamide. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. The sucrose and the appropriate amount of dextrin, mixed, granulated, dried, mixed with 0.5% magnesium stearate, compressed into tablets.
实施例 6: 片剂的制备  Example 6: Preparation of tablets
按照下列用量称取原料中药材及格列本脲: 地黄 1200重量份, 黄芪 400重量份, 山药 200重量份, 葛根 2000重量份, 天花粉 2000重量份, 玉米须 2000重量份, 南五味子 400重量份, 格列本脲 1. 5重量份 。  Weigh the raw Chinese herbal medicine and glibenclamide according to the following dosage: 1200 parts by weight of Radix Rehmanniae, 400 parts by weight of Astragalus, 200 parts by weight of yam, 2000 parts by weight of puerarin, 2000 parts by weight of geranium, 2000 parts by weight of corn, 400 parts by weight of Schisandra chinensis. 5重量份。 glibenclamide 1. 5 parts by weight.
取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混勾, 制成颗粒, 干燥, 拌入 0. 5 %硬脂酸镁, 压制成片剂。  Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. % 脲 和 和 和 和 和 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。
实施例 7: 颗粒剂的制备  Example 7: Preparation of granules
按照下列用量称取原料中药材及格列本脲- 地黄 600重量份, 黄芪 200重量份, 山药 100重量份 , 葛根 1000重量份, 天花粉 1000重量份, 玉米须 1000重量份, 南五味子 200重量份, 格列本脲 0. 2重量份。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混勾、 制成颗粒剂。  Weigh the raw Chinese herbal medicine and 600 parts by weight of glibenclamide-rehmannia, 200 parts by weight of astragalus, 100 parts by weight of yam, 1000 parts by weight of puerarin, 1000 parts by weight of geranium, 1000 parts by weight of corn, and 200 parts by weight of schisandra chinensis. 2重量份。 Glyburide 0. 2 parts by weight. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. Lebenone and appropriate amount of dextrin, mixed with hooks, made into granules.
实施例 8: 软胶囊剂的制备  Example 8: Preparation of soft capsules
按照下列用量称取原料中药材及格列本脲- 地黄 900重量份, 黄芪 300重量份, 山药 150重量份, 葛根 1500重量份, 天花粉 1500重量份, 玉米须 1500重量份, 南五味子 300重量份, 格列本脲 0. 2重量份 。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓縮至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲混 匀, 再加入等量的聚乙二醇 -400和少量的丙三醇, 混匀, 制成软胶囊。 Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages - 重量份。 Respectively, 900 parts by weight of radix, 300 parts by weight of jaundice, 150 parts by weight of yam, 1500 parts by weight of pueraria, 1500 parts by weight of geranium, 1500 parts by weight of corn, 300 parts by weight of schisandra, and 0.2 parts by weight of glibenclamide. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, Corn, and boil for one hour for 5 hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, added. The glibenclamide is mixed, and an equal amount of polyethylene glycol-400 and a small amount of glycerin are added and mixed to prepare a soft capsule.
实施例 9: 散剂的制备  Example 9: Preparation of powder
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 900重量份, 黄芪 300重量份, 山药 150重量份, 葛根 1500重量份, 天花粉 1500重量份, 玉米须 1500重量份, 南五味子 300重量份, 格列本脲 1重量份 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄芪、 南五味子、 山药粉碎粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲混 匀, 制成散剂。  900 parts by weight of rehmannia, 300 parts by weight of astragalus, 150 parts by weight of yam, 1500 parts by weight of puerarin, 1500 parts by weight of geranium powder, 1500 parts by weight of corn, 300 parts by weight of schisandra, 1 part by weight of glibenclamide, radix pueraria, puerarin The corn must be boiled for one hour for five hours, filtered, and the filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, yam crushed coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and mixed with glibenclamide. Into the powder.
实施例 10: 丸剂的制备  Example 10: Preparation of pellets
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 600重量份, 黄芪 200重量份, 山药 100重量份 , 葛根 1000重量份, 天花 粉 1000重量份, 玉米须 1000重量份, 南五味子 200重量份, 格列本脲 1重量份。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄芪、 南五味子、 山药粉碎成粗粉, 与浓縮液拌匀, 干燥, 粉碎成细粉, 混匀。 水泛为 丸, 干燥, 用黑氧化铁、 滑石粉和适量粘合剂, 并加入格列本脲, 打光包衣, 干燥, 制 成丸剂。  600 parts by weight of Rehmannia glutinosa, 200 parts by weight of Astragalus, 100 parts by weight of yam, 1000 parts by weight of Pueraria, 1000 parts by weight of Tianhua powder, 1000 parts by weight of corn, 200 parts by weight of Schisandra chinensis, and 1 part by weight of glibenclamide. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours, filter, and concentrate the filtrate to the appropriate amount. Astragalus, Schisandra, Yam pulverized into coarse powder, mix well with concentrate, dry, pulverize into fine powder, mix uniform. The water is pill, dried, black iron oxide, talc and an appropriate amount of binder, and added to the glibenclamide, light-coated, dried, and pelletized.
实施例 11: 丸剂的制备  Example 11: Preparation of pellets
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 900重量份, 黄芪 200重量份, 山药 130重量份, 葛根 1100重量份, 天花粉 1200重量份, 玉米须 1300重量份 , 南五味子 250重量份, 格列本脲 0. 5重量份。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 混匀。水泛为丸, 干燥, 用黑氧化铁、 滑石粉和适量粘合剂, 并加入格列本脲, 打光包衣, 干燥, 制成丸 剂。  500 parts by weight of rehmannia, 200 parts by weight of astragalus, 130 parts by weight of yam, 1100 parts by weight of puerarin, 1200 parts by weight of trichosanthin, 1300 parts by weight of corn, 250 parts by weight of schisandra, and 0.5 parts by weight of glibenclamide. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, Corn, and boil for one hour. Add the filtrate to the appropriate amount. The scutellaria, schisandra and yam are pulverized into a coarse powder. Mix well with the concentrate, dry, pulverize into fine powder, and mix. . The water is pill, dried, black iron oxide, talc and an appropriate amount of binder, and added to the glibenclamide, light-coated, dried, and made into a pellet.
实施例 12: 丸剂的制备 按照下列用量称取原料中药材及格列本脲: Example 12: Preparation of pellets Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 750重量份, 黄芪 250重量份, 山药 130重量份, 葛根 1300重量份, 天花粉 1300重量份, 玉米须 1300重量份 , 南五味子 250重量份, 格列本脲 0. 5重量份。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 混匀。水泛为丸, 干燥, 用黑氧化铁、 滑石粉和适量粘合剂, 并加入格列本脲, 打光包衣, 干燥, 制成丸 剂。  Rehmannia 750 parts by weight, Astragalus 250 parts by weight, Yam 130 parts by weight, Pueraria 1300 parts by weight, Trichosanthin 1300 parts by weight, Corn 1300 parts by weight, Schisandra chinensis 250 parts by weight, glibenclamide 0.5 parts by weight. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, Corn, and boil for one hour. Add the filtrate to the appropriate amount. The scutellaria, schisandra and yam are pulverized into a coarse powder. Mix well with the concentrate, dry, pulverize into fine powder, and mix. . The water is pill, dried, black iron oxide, talc and an appropriate amount of binder, and added to the glibenclamide, light-coated, dried, and made into a pellet.
实施例 13: 片剂的制备  Example 13: Preparation of tablets
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 1000重量份, 黄芪 220重量份, 山药 110重量份, 葛根 1000重量份, 天花粉 1700重量份, 玉米须 1500重量份, 南五味子 205重量份, 格列本脲 0. 4重量份 。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混匀, 制成颗粒, 干燥, 拌入 0. 5%硬脂酸镁, 压制成片剂。  1000 parts by weight of Radix Rehmanniae, 220 parts by weight of Astragalus, 110 parts by weight of yam, 1000 parts by weight of puerarin, 1700 parts by weight of Tianhua powder, 1500 parts by weight of corn, 205 parts by weight of Schisandra chinensis, 0.4 parts by weight of glibenclamide. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. The lenamide and the appropriate amount of dextrin, mixed, granulated, dried, mixed with 0.5% magnesium stearate, compressed into tablets.
实施例 14: 颗粒剂的制备  Example 14: Preparation of granules
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 650重量份, 黄芪 205重量份, 山药 120重量份 , 葛根 1700重量份, 天花粉 1500重量份, 玉米须 1100重量份, 南五味子 220重量份, 格列本脲 0. 8重量份。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲和 适量糊精, 混匀、 制成颗粒剂。  Rehmannia 650 parts by weight, Astragalus 205 parts by weight, Yam 120 parts by weight, Pueraria 1700 parts by weight, Trichosanthin 1500 parts by weight, Corn 1100 parts by weight, Schisandra chinensis 220 parts by weight, Glyburide 0. 8 parts by weight. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. Lebenone and an appropriate amount of dextrin, mixed and made into granules.
实施例 15: 软胶囊剂的制备  Example 15: Preparation of Soft Capsules
按照下列用量称取原料中药材及格列本脲:  Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 950重量份, 黄芪 350重量份, 山药 180重量份, 葛根 1500重量份, 天花粉 1100重量份, 玉米须 1200重量份, 南五味子 280重量份, 格列本脲 1. 2重量份 。 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓缩至适量, 黄 芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲混 匀, 再加入等量的聚乙二醇- 400和少量的丙三醇, 混匀, 制成软胶囊。  Rehmannia 950 parts by weight, Astragalus 350 parts by weight, Yam 180 parts by weight, Pueraria 1500 parts by weight, Trichosanthin 1100 parts by weight, Corn 1200 parts by weight, Schisandra 280 parts by weight, Glibenclamide 1.2 parts by weight. Take Radix Rehmanniae, Radix Puerariae, Trichosanthin, and Corn. Add boiling water for five hours. Filter it. The filtrate is concentrated to an appropriate amount. Astragalus, Schisandra, Yam is pulverized into a coarse powder, mixed with the concentrate, dried, pulverized into fine powder, and added to the grid. The lebenol is mixed, and an equal amount of polyethylene glycol-400 and a small amount of glycerin are added and mixed to prepare a soft capsule.
实施例 16: 散剂的制备 按照下列用量称取原料中药材及格列本脲: Example 16: Preparation of a powder Weigh the raw Chinese herbal medicines and glibenclamide according to the following dosages:
地黄 800重量份, 黄芪 210重量份, 山药 100重量份, 葛根 1200重量份, 天花粉 1000重量份, 玉米须 1700重量份, 南五味子 330重量份, 格列本脲 0. 9重量份 取地黄、 葛根、 天花粉、 玉米须加水煎煮一次五小时, 滤过, 滤液浓縮至适量, 黄 芪、南五味子、 山药粉碎粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 加入格列本脲混匀, 制成散剂。  Resveratrol, radix rehmanniae, radix rehmanniae, radix rehmanniae, rehmannia glutinosa, rehmannia glutinosa, rehmannia glutinosa, rehmannia glutinosa, rehmannia glutinosa, rehmannia glutinosa, rehmannia glutinosa, radix granules, granules, 1200 parts by weight, 1200 parts by weight, 1000 parts by weight , Trichosanthin, corn must be boiled for one hour for five hours, filtered, the filtrate is concentrated to the appropriate amount, Astragalus, Schisandra, yam crushed coarse powder, mixed with the concentrate, dried, pulverized into fine powder, added to glibenclamide Evenly, made into powder.
实施例 17: 滴丸剂的制备  Example 17: Preparation of a pill
按照下列用量称取原料中药材及格列本脲- 地黄 636重量份, 黄芪 212重量份, 山药 106重量份, 葛根 1060重量份, 天花粉 1060重量份, 玉米须 1060重量份, 南五味子 212重量份, 格列本脲 1重量份 。 取葛根、 地黄、 玉米须、 天花粉、 黄芪、 南五味子、 山药加水煎煮一次, 滤过, 滤 液浓缩至适量, 放冷, 加乙醇使溶液含醇量为 60%, 静置 24小时, 滤过, 滤液浓缩至 无醇味,加入 2倍水量于浓缩膏中,搅拌溶解完全后,通过预先处理过的大孔吸附树脂, 并以水洗脱至流出液无色后, 以 70%乙醇洗脱, 收集洗脱液至无色后, 浓缩得浸膏。 取 聚乙二醇 6000 (PEG-6000)和硬脂酸适量至容器中,加热至 100~110°C,待全部熔融后, 加入格列本脲和上述浸膏, 分散均匀后, 以液体石蜡为冷却剂滴制成丸, 取出滴丸, 甩 干石蜡, 即得滴丸剂。  Weigh the raw Chinese herbal medicine and 636 parts by weight of glibenclamide-dihedron, 212 parts by weight of astragalus, 106 parts by weight of yam, 1060 parts by weight of puerarin, 1060 parts by weight of trichosanthin, 1060 parts by weight of corn, and 212 parts by weight of schisandra chinensis. Glibenclamide 1 part by weight. Take radix puerariae, rehmannia root, corn stalk, trichosanthin, astragalus, schisandra, yam and boiled water once, filter, filter the filtrate to the appropriate amount, let cool, add ethanol to make the solution alcohol content 60%, let stand for 24 hours, filter The filtrate is concentrated to a non-alcoholic taste. Add 2 times of water to the concentrated paste, stir and dissolve completely, and then pass through the pretreated macroporous adsorption resin, and elute with water until the effluent is colorless, and elute with 70% ethanol. After collecting the eluate until it is colorless, it is concentrated to obtain an extract. Take polyethylene glycol 6000 (PEG-6000) and stearic acid into the container, heat to 100 ~ 110 ° C, after all melting, add glibenclamide and the above extract, evenly dispersed, with liquid paraffin Pills are prepared by dropping the coolant, and the dropping pills are taken out, and the paraffin is dried, that is, the pills are obtained.
实施例 18: 滴丸剂的制备  Example 18: Preparation of a pill
按照下列用量称取原料中药材及格列本脲- 地黄 750重量份, 黄芪 250重量份, 山药 130重量份, 葛根 1300重量份, 天花粉 1300重量份, 玉米须 1300重量份 , 南五味子 250重量份,格列本脲 0. 5重量份。 取葛根、 地黄、 玉米须、 天花粉、 黄芪、 南五味子、 山药加水煎煮一次, 滤过, 滤 液浓缩至适量, 放冷, 加乙醇使溶液含醇量为 60%, 静置 24小时, 滤过, 滤液浓缩至 无醇味,加入 2倍水量于浓缩膏中,搅拌溶解完全后,通过预先处理过的大孔吸附树脂, 并以水洗脱至流出液无色后, 以 70%乙醇洗脱, 收集洗脱液至无色后, 浓缩得浸膏。取 聚乙二醇 6000 (PEG-6000)和硬脂酸适量至容器中,加热至 100~110°C,待全部熔融后, 加入格列本脲和上述浸膏, 分散均勾后, 以液体石蜡为冷却剂滴制成丸, 取出滴丸, 甩 干石蜡, 即得滴丸剂。  Weigh the raw Chinese herbal medicine and 750 parts by weight of glibenclamide-rehmannia, 250 parts by weight of astragalus, 130 parts by weight of yam, 1300 parts by weight of puerarin, 1300 parts by weight of geranium, 1300 parts by weight of corn, and 250 parts by weight of schisandra chinensis. 5重量份。 Glyburide 0. 5 parts by weight. Take radix puerariae, rehmannia root, corn stalk, trichosanthin, astragalus, schisandra, yam and boiled water once, filter, filter the filtrate to the appropriate amount, let cool, add ethanol to make the solution alcohol content 60%, let stand for 24 hours, filter The filtrate is concentrated to a non-alcoholic taste. Add 2 times of water to the concentrated paste, stir and dissolve completely, and then pass through the pretreated macroporous adsorption resin, and elute with water until the effluent is colorless, and elute with 70% ethanol. After collecting the eluate until it is colorless, it is concentrated to obtain an extract. Take PEG 6000 (PEG-6000) and stearic acid into the container, heat to 100 ~ 110 ° C, after all melting, add glibenclamide and the above extract, after the dispersion is hooked, to the liquid The paraffin is made into a pellet of a coolant, and the pellet is taken out, and the paraffin is dried, and the pellet is obtained.

Claims

权利要求 Rights request
1、 一种治疗糖尿病的药物组合物, 其特征在于该药物组合物的活性成分是由如下比例 的原料药制成的- 地黄 600-1200重量份, 黄芪 200-400重量份, 山药 100-200重量份, 葛根 1000-2000 重量份, 天花粉 1000-2000重量份, 玉米须 1000-2000重量份, 南五味子 200-400重量 份, 格列本脲 0. 2- 1. 5重量份。 A pharmaceutical composition for treating diabetes, characterized in that the active ingredient of the pharmaceutical composition is prepared from the following ratio of the raw material medicine: 600-1200 parts by weight of Radix Rehmanniae, 200-400 parts by weight of Astragalus, 100-200 of Yam重量份, 葛根 1000-2000 parts by weight, trichosant 1000-2000 parts by weight, corn must be 1000-2000 parts by weight, schisandra chinensis 200-400 parts by weight, glibenclamide 0. 2-1.5 parts by weight.
2、 如权利要求 1所述的药物组合物, 其特征在于其活性成分是由如下比例的原料药制 成的:  The pharmaceutical composition according to claim 1, wherein the active ingredient is prepared from the following ratio of the drug substance:
地黄 600- 900重量份, 黄芪 200- 300重量份, 山药 100- 150重量份, 葛根 1000-1500重 量份, 天花粉 1000- 1500重量份, 玉米须 1000- 1500重量份, 南五味子, 200- 300重量 份, 格列本脲 0. 2-1. 0重量份。 Rehmannia 600-900 parts by weight, Astragalus 200-300 parts by weight, Yam 100-150 parts by weight, Pueraria 1000-1500 parts by weight, Trichosanthin 1000-1500 parts by weight, Corn must-have 1000-1500 parts by weight, Schisandra chinensis, 200-300 weight份份份, 格列本尿 0. 2-1. 0 parts by weight.
3、 如权利要求 2所述的药物组合物, 其特征在于其活性成分是由如下比例的原料药制 成的- 地黄 636重量份, 黄芪 212重量份, 山药 106重量份, 葛根 1060重量份, 天花粉 1060 重量份, 玉米须 1060重量份, 南五味子 212重量份, 格列本脲 1重量份。  3. The pharmaceutical composition according to claim 2, wherein the active ingredient is prepared from the following ratios of raw materials: 636 parts by weight of rehmannia, 212 parts by weight of astragalus, 106 parts by weight of yam, and 1060 parts by weight of puerarin. 1060 parts by weight of trichosanthin, 1060 parts by weight of corn, 212 parts by weight of Schisandra chinensis, and 1 part by weight of glibenclamide.
4、 如权利要求 1、 2或 3所述的药物组合物, 其特征在于它是滴丸剂、 丸剂、 片剂、 胶 囊剂、 颗粒剂、 软胶囊剂或散剂。  A pharmaceutical composition according to Claim 1, 2 or 3, which is a pill, a pill, a tablet, a capsule, a granule, a soft capsule or a powder.
5、一种制备权利要求 4所述药物组合物的制备方法, 其特征在于该方法含有如下步骤: 取葛根、 地黄、 玉米须、 天花粉、 黄芪、 南五味子、 山药加水煎煮一次, 滤过, 滤液浓 缩至适量, 放冷, 加乙醇使溶液含醇量为 60%, 静置 24小时, 滤过, 滤液浓缩至无醇 味, 加入 2倍水量于浓缩膏中, 搅拌溶解完全后, 通过预先处理过的大孔吸附树脂, 并 以水洗脱至流出液无色后, 以 70%乙醇洗脱, 收集洗脱液至无色后, 浓缩得浸膏。 取聚 乙二醇 6000 (PEG-6000)和硬脂酸适量至容器中, 加热至 100~110°C, 待全部熔融后, 加入格列本脲和上述浸膏, 分散均匀后, 以液体石蜡为冷却剂滴制成丸, 取出滴丸, 甩 干石蜡, 即得滴丸剂。  A method for preparing the pharmaceutical composition according to claim 4, characterized in that the method comprises the steps of: taking radix pueraria, rehmannia, corn mustard, trichosanthin, astragalus, schisandra, yam and boiling water once, filtering, The filtrate is concentrated to an appropriate amount, allowed to cool, and ethanol is added to make the solution contain 60% alcohol. It is allowed to stand for 24 hours, filtered, and the filtrate is concentrated to an alcohol-free taste. Add 2 times of water to the concentrated paste, stir and dissolve completely, and pass in advance. The treated macroporous resin was adsorbed and eluted with water until the effluent was colorless, and eluted with 70% ethanol. The eluate was collected until it was colorless, and concentrated to obtain an extract. Take polyethylene glycol 6000 (PEG-6000) and stearic acid into the container, heat to 100~110 °C, after all melting, add glibenclamide and the above extract, disperse evenly, then use liquid paraffin Pills are prepared by dropping the coolant, and the dropping pills are taken out, and the paraffin is dried, that is, the pills are obtained.
6、一种制备权利要求 4所述药物组合物的制备方法, 其特征在于该方法含有如下步骤: 取地黄、 葛根、 天花粉、 玉米须加水煎煮五小时, 滤过, 滤液浓缩, 黄芪、 南五味子、 山药粉碎成细粉, 与浓缩液到一步制粒机中制成颗粒, 加入格列本脲, 压制成丸剂。 A method for preparing a pharmaceutical composition according to claim 4, characterized in that the method comprises the following steps: taking rehmannia root, puerarin, trichosanthin, corn, and boiling water for five hours, filtering, concentration of the filtrate, jaundice, south Schisandra and yam are pulverized into fine powder, and the concentrate is granulated in a one-step granulator, and glibenclamide is added to be compressed into a pellet.
7、一种制备权利要求 4所述药物组合物的制备方法, 其特征在于该方法含有如下步骤: 取地黄、 葛根、 天花粉、 玉米须加水煎煮五小时, 滤过, 滤液浓缩, 黄芪、 南五味子、 山药粉碎成粗粉, 与浓缩液拌匀, 干燥, 粉碎成细粉, 制成药粉; 将所得药粉, 混匀, 水泛为丸, 干燥, 并加入格列本脲, 用黑氧化铁、 滑石粉和粘合剂, 打光包衣, 制成丸 剂。 A method for preparing a pharmaceutical composition according to claim 4, characterized in that the method comprises the following steps: taking rehmannia, pueraria, trichosanthin, corn, and boiling water for five hours, filtering, concentration of the filtrate, jaundice, south Schisandra and yam are pulverized into coarse powder, mixed with concentrated solution, dried, pulverized into fine powder, and made into powder; the obtained powder is mixed, water is pelleted, dried, and glibenclamide is added, and black iron oxide is added. , talc and binder, light coating, made into pellets.
8、 如权利要求 7所述药物组合物的制备方法, 其特征在于: 取所得药粉, 混匀。 以机 械制丸机制成丸, 干燥, 加入格列本脲, 用黑氧化铁、 滑石粉和粘合剂, 打光包衣, 干 燥, 制成丸剂。  8. A method of preparing a pharmaceutical composition according to claim 7, wherein the obtained powder is taken and mixed. The pellets were prepared by a mechanical pelleting machine, dried, and glibenclamide was added, and the coating was dried with a black iron oxide, talc, and a binder, and dried to prepare a pellet.
9、 如权利要求 7所述药物组合物的制备方法, 其特征在于: 取所得药粉, 混匀。 以一 步制粒机制成颗粒, 加入格列本脲, 压制成丸剂。  9. A method of preparing a pharmaceutical composition according to claim 7, wherein the obtained powder is taken and mixed. Granules were prepared in a one-step granulator, and glibenclamide was added and compressed into pellets.
10、 如权利要求 7所述药物组合物的制备方法, 其特征在于: 取所得药粉, 加入格列本 脲和 0. 2%羧甲基纤维素钠, 混匀、 制粒, 充填, 制成胶囊剂。  The method for preparing a pharmaceutical composition according to claim 7, wherein the obtained powder is obtained by adding glibenclamide and 0.2% sodium carboxymethylcellulose, mixing, granulating, and filling. Capsules.
11、如权利要求 7所述药物组合物的制备方法, 其特征在于: 取所得药粉, 加入格列本 脲和淀粉, 混匀, 制成颗粒, 干燥, 拌入适量硬脂酸镁, 压成片剂。  The method for preparing a pharmaceutical composition according to claim 7, wherein: the obtained powder is added, glibenclamide and starch are added, mixed, granulated, dried, and mixed with an appropriate amount of magnesium stearate, and pressed. tablet.
12、如权利要求 7所述药物组合物的制备方法, 其特征在于该方法包括如下步骤:取所 得药粉, 加入格列本脲和糊精, 混匀、 制成颗粒剂。  A method of preparing a pharmaceutical composition according to claim 7, wherein the method comprises the steps of: taking the obtained powder, adding glibenclamide and dextrin, and mixing to prepare a granule.
13、 如权利要求 7所述药物组合物的制备方法, 其特征在于: 取所得药粉, 加入格列本 脲混勾, 再加入等量聚乙二醇 -400和少量的丙三醇, 混匀, 压制成软胶囊。  The method for preparing a pharmaceutical composition according to claim 7, wherein: the obtained powder is added, and the glibenclamide is added to the hook, and then an equal amount of polyethylene glycol-400 and a small amount of glycerin are added, and the mixture is mixed. , pressed into soft capsules.
14、如权利要求 7所述药物组合物的制备方法, 其特征在于: 取所得药粉, 加入格列本 脲, 混匀、 制成散剂。  The method for preparing a pharmaceutical composition according to claim 7, wherein the obtained powder is added, glibenclamide is added, and the mixture is mixed to prepare a powder.
PCT/CN2006/000952 2005-05-18 2006-05-12 A pharmaceutical composition for treating diabetes and process thereof WO2006122485A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN200510034644.3 2005-05-18
CN200510034644 2005-05-18
CN200610075069.6 2006-03-31
CNB2006100750696A CN100355442C (en) 2005-05-18 2006-03-31 Medicinal composition for treating diabets, and its prepn. method

Publications (1)

Publication Number Publication Date
WO2006122485A1 true WO2006122485A1 (en) 2006-11-23

Family

ID=37388762

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2006/000952 WO2006122485A1 (en) 2005-05-18 2006-05-12 A pharmaceutical composition for treating diabetes and process thereof

Country Status (3)

Country Link
CN (1) CN100355442C (en)
RU (1) RU2362578C1 (en)
WO (1) WO2006122485A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011012615A2 (en) 2009-07-30 2011-02-03 Laboratoires Expanscience Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra
WO2011012612A2 (en) 2009-07-30 2011-02-03 Laboratoires Expanscience Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical compositions comprising same
CN103355674A (en) * 2013-07-23 2013-10-23 绍兴文理学院 Pork tripe medicated diet and its making process
CN104544054A (en) * 2014-12-19 2015-04-29 李进 Antidiabetic granule and preparation method thereof
CN106334062A (en) * 2016-09-21 2017-01-18 四川易创生物科技有限公司 Traditional Chinese medicine composition for treating both deficiency of qi and blood and preparation method of traditional Chinese medicine composition

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101934036B (en) * 2010-08-26 2013-04-24 广州白云山中一药业有限公司 Method for preparing medicament for treating diabetes mellitus
CN102813840B (en) * 2011-06-07 2014-08-06 广州白云山中一药业有限公司 Application of pharmaceutical composition in preparing medicines used for preventing and treating diabetic cardiomyopathy
CN102836349B (en) * 2011-06-21 2014-10-15 广州白云山中一药业有限公司 Traditional Chinese medicine composition for treating diabetes and preparation method thereof
CN104991032B (en) * 2015-07-23 2016-06-08 北京市药品检验所 Differentiate to adulterate in Fructus Schisandrae Chinensis the thin layer chromatography of Fructus Schisandrae Sphenantherae
CN105233032A (en) * 2015-10-20 2016-01-13 李竹岩 Traditional Chinese medicine for treating diabetes
CN108079205B (en) * 2016-11-21 2021-01-19 广州白云山中一药业有限公司 Method for coating traditional Chinese medicine matrix with glibenclamide
CN111567717A (en) * 2020-05-27 2020-08-25 河南大学 Chinese yam mucilage-nano zinc oxide solution and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562188A (en) * 2004-03-17 2005-01-12 北京奇源益德药物研究所 Wasting-thirst preparaton and preparation method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562188A (en) * 2004-03-17 2005-01-12 北京奇源益德药物研究所 Wasting-thirst preparaton and preparation method

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011012615A2 (en) 2009-07-30 2011-02-03 Laboratoires Expanscience Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra
WO2011012612A2 (en) 2009-07-30 2011-02-03 Laboratoires Expanscience Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical compositions comprising same
KR20120052991A (en) * 2009-07-30 2012-05-24 라보라토이레즈 익스펜사이언스 Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra
US8586107B2 (en) 2009-07-30 2013-11-19 Laboratoires Expanscience Schisandra sphenanthera fruit extract and cosmetic, dermatological, and nutraceutical compositions comprising same
US8758833B2 (en) 2009-07-30 2014-06-24 Laboratoires Expanscience Cosmetic composition for the treatment of acne comprising a peptide extract of Schisandra
KR101713357B1 (en) 2009-07-30 2017-03-22 라보라토이레즈 익스펜사이언스 Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra
CN103355674A (en) * 2013-07-23 2013-10-23 绍兴文理学院 Pork tripe medicated diet and its making process
CN104544054A (en) * 2014-12-19 2015-04-29 李进 Antidiabetic granule and preparation method thereof
CN106334062A (en) * 2016-09-21 2017-01-18 四川易创生物科技有限公司 Traditional Chinese medicine composition for treating both deficiency of qi and blood and preparation method of traditional Chinese medicine composition

Also Published As

Publication number Publication date
RU2362578C1 (en) 2009-07-27
CN100355442C (en) 2007-12-19
CN1861176A (en) 2006-11-15

Similar Documents

Publication Publication Date Title
WO2006122485A1 (en) A pharmaceutical composition for treating diabetes and process thereof
CN102225149B (en) Traditional Chinese medicine compound for treating diabetes and preparation method thereof
CN101352512B (en) Chinese medicine composition for treating diabetes and method for preparing the same
CN105288215A (en) High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof
CN102961596B (en) Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of for traditional Chinese medicine composition
CN103599215A (en) Blood sugar-reducing medicament
CN101637561A (en) Fritillary-loquat medicinal composition and preparation method thereof
CN102145120B (en) Traditional Chinese medicine composition suitable for treating Type II diabetes
CN102362966A (en) Unibract fritillary bulb and loquat leaf medicinal composition and preparation method thereof
WO2006122454A1 (en) A pharmaceutical composition for treating diabetes and preparation method thereof
CN112755160A (en) Traditional Chinese medicine composition for improving postoperative prognosis of breast cancer and application thereof
CN103599343A (en) Pharmaceutical composition for treating diabetes, and preparation method and application thereof
CN101147767B (en) Preparation method of medicinal composition for treating acne
CN107854671A (en) A Na series anaesthetic intragastric floating sustained-release preparations and preparation method thereof
CN101219200B (en) Traditional Chinese medicine soft capsule and preparing method thereof
CN107997170B (en) Composition with blood fat reducing function and preparation method thereof
CN102178891B (en) Chinese medicinal dispersible tablets for treating gastritis and preparation method thereof
CN101884769B (en) Traditional Chinese medicine for treating autoimmune thyroiditis and production method
CN103494894A (en) Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof
CN103494916A (en) Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof
CN102058830B (en) Medicinal composition preparation and preparation method thereof
CN107669860A (en) A kind of Chinese medicine composition and its application with blood sugar reducing function
CN102579801B (en) Traditional Chinese medicine preparation for treating diabetic syndrome and preparation method of same
CN1136954A (en) Method for producing Chinese patent medicine for curing diabetes and its pill
CN1223360C (en) Chinese medicine for treating chest paralysis

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 2007146284

Country of ref document: RU

Ref document number: 1200702711

Country of ref document: VN

122 Ep: pct application non-entry in european phase

Ref document number: 06741842

Country of ref document: EP

Kind code of ref document: A1